Zydus Lifesciences Ltd AGM

Zydus Gets Four USFDA Observations at Baddi Plant

 Copy Link

The company said it will work with the US regulator to resolve the points raised as quickly as possible.

Zydus Wins USFDA’s Tentative Approval to Market Ibrutinib Tablets in US

 Copy Link

This development comes after a USFDA inspection at one of Zydus' oncology facilities earlier this year.

Zydus Lifesciences’ oncology unit gets 2 USFDA observations

 Copy Link

In its filing with the bourses, Zydus informed that these observations received were minor, and not related to data integrity.

Top Stocks for Today - 19th June 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Jio Financial Service, Hero MotoCorp, Abbott India, etc.

Top Stocks for Today - 12th June 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Hindustan Copper, Maruti Suzuki, Zydus Lifesciences, etc.

Zydus Lifesciences Gets Clean USFDA Nod for Ankleshwar API Facility

 Copy Link

For Zydus, this clean report adds a layer of credibility to its US compliance track record especially since the Ankleshwar facility is a key site for its API exports.

Zydus Lifesciences Subsidiary Zynext to Acquire 5.9% Stake in Agenus for $16 Million

 Copy Link

The acquisition is priced at $7.50 per share and will be completed in cash within 60 days, subject to regulatory approvals

Zydus Gets USFDA Fast Track Nod for ALS Drug Usnoflast

 Copy Link

It provides benefits such as faster approval, priority review and a more open line of communication with the F.D.A.

Zydus Lifesciences Gets USFDA Nod for Generic Absorica to Treat Severe Acne

 Copy Link

They are the generic form of Absorica, a well-known prescription treatment for severe and hard to treat forms of nodular acne that the patient has not responded well to other treatments with.

Zydus Lifesciences Q4 Revenue Rises 18% YoY to ₹6,528 Crore

 Copy Link

Consolidated revenue for the March quarter rose 18% YoY to ₹6,528 crore.